At 100 μM, diclofenamide increased human ClC-1 chloride currents in transfected HEK293T cells. In isolated rat muscle, 50–100 μM increased resting chloride conductance without a significant potassium-conductance change. The cellular activation shift depended on the recording protocol; a causal acidification mechanism and in vivo efficacy were not established by these experiments. [2]
Binding to human carbonic anhydrases I and II
Biochemical assay · Purified human carbonic anhydrases I and II from human erythrocytes; native nano-ESI mass spectrometry. [1]
Individual-ligand measurements showed stronger binding to hCA II than hCA I. Six-ligand competition measurements gave similar Kd values. These are dissociation constants, not inhibition potencies; the competition experiment is assay validation rather than a therapeutic combination.
Literature-Reported Treatment Conditions
- Treatment concentration
- hCA I individual assay: 1, 2, 3 and 4 μM DCP with 5 μM protein (SI Table S1). Competition assay: 4 μM DCP with 20 μM hCA I or II; other ligands 4 μM each except indapamide 15 μM.
- Exposure duration
- Protein–ligand mixtures equilibrated for at least 30 min at room temperature.
- Method
- Native nano-electrospray ionization MS using ~250 nm inner-diameter emitter tips.
- Vehicle
- Aqueous 70 mM ammonium acetate, pH 7.4.
- Co-treatment
- Competition check used ethoxzolamide, brinzolamide, furosemide, indapamide and acetazolamide alongside dichlorophenamide.
- Reported limits
- The reviewed SI Table S1 describes hCA I concentrations; hCA II individual-assay concentrations are not specified in the reviewed locations and are not borrowed from hCA I. Table 2 and SI Table S2 do not specify SD versus SEM.
Methods and source locations
Compound reported in the paper: Diclofenamide (dichlorophenamide); Compound label in the paper: dichlorophenamide; L4 in Figure 5
Applies to the named compound in the reported assay; no Adooq lot or formulation validation.
Table 2 and footnotes; Figures 1/5 and captions; Experimental Section; SI Scheme S1 and Table S1
Binding to hCA I in individual-ligand assay: ~250 nm emitters; average of triplicate measurements at different ligand concentrations. Table 2 does not define the ± statistic. — Table 2, dichlorophenamide row, hCA I single column; footnote a
Binding to hCA II in individual-ligand assay: Same measurement design; uncertainty retained as tabulated. — Table 2, dichlorophenamide row, hCA II single column; footnote a
Six-ligand competition binding assay: Triplicate measurements of a single mixture; ± statistic not defined in Table 2. — Table 2, dichlorophenamide row, competition columns; footnote b; Figure 5
Recombinant human ClC-1 chloride currents
Cell-based study · HEK293T cells transiently expressing wild-type human ClC-1. [2]
DCP increased steady-state inward chloride current at −80 mV, slowed deactivation and shifted channel activation toward more negative voltages. A longer pulse protocol confirmed a smaller but significant activation shift. These cellular responses do not establish direct binding to ClC-1 or prove intracellular acidification as the causal route.
Literature-Reported Treatment Conditions
- Treatment concentration
- 100 μM
- Exposure duration
- Steady state after 2–4 min.
- Method
- Whole-cell patch clamp at 20–22°C; within-cell drug-free baseline comparison.
- Vehicle
- DMSO not above 0.2% v/v in recording solutions (Methods 2.5).
- Reported limits
- Methods 2.5 says pipette pH 7.4, whereas Results 3.1 says 7.2; exact pipette pH is unresolved. Vehicle-only response is not separately quantified in the reviewed locations.
Methods and source locations
Compound reported in the paper: Diclofenamide (dichlorphenamide); Compound label in the paper: DCP
Compound-level relevance to diclofenamide; supplier material, not an Adooq lot.
Methods 2.1/2.5; Results 3.1, pp.9–10; Table 1 p.24; Figure 1 and caption p.26
Steady-state chloride current change at −80 mV, 400 ms test protocol: Paired Student t test against the same cells before drug; mean ± SEM. — Results 3.1, printed p.9; Figure 1A–D; Table 1 and caption
Negative shift of activation voltage dependence, 400 ms protocol: Paired Student t test; mean ± SEM. — Results 3.1, printed p.9; Figure 1D; Table 1
Activation shift with prolonged test pulses to address incomplete deactivation: 800 ms test pulses; paired Student t test; mean ± SEM. — Results 3.1, printed p.10; Table 1, DCP 800 ms rows
Resting chloride conductance in isolated rat muscle
Cell-based study · Isolated extensor digitorum longus muscle fibers from adult male Wistar rats (3 months old); ex vivo bath exposure. [2]
DCP increased resting sarcolemmal chloride conductance at both tested concentrations, without a significant effect on potassium conductance. No significant difference between 50 and 100 μM was reported. This was isolated-muscle exposure, not an in vivo efficacy test.
Literature-Reported Treatment Conditions
- Treatment concentration
- 50 or 100 μM
- Exposure duration
- 20 min
- Method
- Bath incubation of isolated rat EDL muscle; current-clamp conductance measurement.
- Vehicle
- DMSO not above 0.2% v/v in physiological solution (Methods 2.5).
- Reported limits
- Per-animal replication for individual Figure 2 groups is not specified in the caption. Fiber counts are displayed in the figure; these are not independent animal counts. No systemic DCP dose applies.
Methods and source locations
Compound reported in the paper: Diclofenamide (dichlorphenamide); Compound label in the paper: DCP
Compound-level relevance to diclofenamide; supplier material, not an Adooq lot.
Methods 2.2/2.3/2.5; Results 3.2; Figure 2 and caption
Resting chloride conductance versus drug-free control: Two intracellular microelectrodes, current clamp, 30°C. gCl calculated as total resting conductance minus potassium conductance; Figure 2 bars mean ± SEM of fibers. — Results 3.2, printed pp.10–11; Figure 2 DCP middle panels; caption p.26
Resting potassium conductance and concentration comparison: Unpaired Student t test versus respective control for plotted conductances; no exact bar-height values inferred. — Results 3.2, printed p.11; Figure 2 DCP panels and caption